|
BMPR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.114100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.312800E-01 |
| Normal-vs-Stage2 |
1.593400E-01 |
| Normal-vs-Stage3 |
2.595200E-03 |
| Normal-vs-Stage4 |
1.9233000000396E-06 |
| Stage1-vs-Stage2 |
3.773600E-01 |
| Stage1-vs-Stage3 |
4.535100E-03 |
| Stage1-vs-Stage4 |
1.30700000000594E-06 |
| Stage2-vs-Stage3 |
4.957000E-01 |
| Stage2-vs-Stage4 |
1.336250E-01 |
| Stage3-vs-Stage4 |
1.795550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.021800E-02 |
| Normal-vs-AfricanAmerican |
7.005100E-04 |
| Normal-vs-Asian |
7.444400E-01 |
| Caucasian-vs-AfricanAmerican |
6.128200E-02 |
| Caucasian-vs-Asian |
6.723600E-01 |
| AfricanAmerican-vs-Asian |
2.170800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.564700E-03 |
| Normal-vs-Female |
6.175600E-02 |
| Male-vs-Female |
3.790000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.315700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.014640E-01 |
| Normal-vs-Age(61-80Yrs) |
7.678500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.119200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.441200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.884200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.094600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.436210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.403610E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.847630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.440200E-01 |
| Normal-vs-Grade 2 |
6.084800E-01 |
| Normal-vs-Grade 3 |
4.1448000000055E-05 |
| Normal-vs-Grade 4 |
1.16480000000863E-06 |
| Grade 1-vs-Grade 2 |
3.597600E-01 |
| Grade 1-vs-Grade 3 |
1.297050E-03 |
| Grade 1-vs-Grade 4 |
1.414730E-04 |
| Grade 2-vs-Grade 3 |
1.224500E-04 |
| Grade 2-vs-Grade 4 |
8.56490000034071E-07 |
| Grade 3-vs-Grade 4 |
5.230200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.338400E-01 |
| Normal-vs-ccB subtype |
1.508090E-02 |
| ccA subtype-vs-ccB subtype |
1.919660E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.018100E-02 |
| Normal-vs-N1 |
4.066000E-02 |
| N0-vs-N1 |
4.543400E-01 |
|
|
